Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: REDHILL BIOPHARMA LTD
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-27 to 2026-03-31
Current total value of award: $733381.75
Description: REDHILL BIOPHARMA LTD-OPAGANIB AS HOST-DIRECTED THERAPEUTIC FOR EBOLA VIRUS DISEASE